These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36287209)

  • 1. Macrophage depletion blocks congenital SARM1-dependent neuropathy.
    Dingwall CB; Strickland A; Yum SW; Yim AK; Zhu J; Wang PL; Yamada Y; Schmidt RE; Sasaki Y; Bloom AJ; DiAntonio A; Milbrandt J
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36287209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
    Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
    Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
    Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
    Elife; 2016 Oct; 5():. PubMed ID: 27735788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical biology of NAD
    Icso JD; Thompson PR
    Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
    Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.
    McGuinness HY; Gu W; Shi Y; Kobe B; Ve T
    Neuroscientist; 2024 Aug; 30(4):473-492. PubMed ID: 37002660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARM1 is a metabolic sensor activated by an increased NMN/NAD
    Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
    Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
    Ko KW; Milbrandt J; DiAntonio A
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
    Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
    Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
    Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
    Elife; 2017 Jan; 6():. PubMed ID: 28095293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.
    Summers DW; Milbrandt J; DiAntonio A
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8746-E8754. PubMed ID: 30150401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
    Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
    Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
    Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
    Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
    Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
    Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1.
    Loreto A; Angeletti C; Gu W; Osborne A; Nieuwenhuis B; Gilley J; Merlini E; Arthur-Farraj P; Amici A; Luo Z; Hartley-Tassell L; Ve T; Desrochers LM; Wang Q; Kobe B; Orsomando G; Coleman MP
    Elife; 2021 Dec; 10():. PubMed ID: 34870595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SARM1 axon degeneration pathway: control of the NAD
    Figley MD; DiAntonio A
    Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration.
    Sasaki Y; Kakita H; Kubota S; Sene A; Lee TJ; Ban N; Dong Z; Lin JB; Boye SL; DiAntonio A; Boye SE; Apte RS; Milbrandt J
    Elife; 2020 Oct; 9():. PubMed ID: 33107823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration.
    Chen YH; Sasaki Y; DiAntonio A; Milbrandt J
    Exp Neurol; 2021 May; 339():113636. PubMed ID: 33548217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.